FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3160490316> ?p ?o ?g. }

• W3160490316 endingPage "1987" @default.
• W3160490316 startingPage "1977" @default.
• W3160490316 abstract "This study assessed the impact of product particle sizes (fine: 106-500 µm; coarse: 500-1000 µm) on oxycodone pharmacokinetics (PK) following nasal insufflation of milled oxycodone extended-release (ER) abuse-deterrent (AD) tablets using immediate-release (IR) non-AD product as reference. Additionally, this study assessed the effects of different excipient to drug ratio (EDR) by comparing two products with fine particle size but different EDRs, again using IR non-AD as the control. Thirty milligrams of oxycodone were administered in each treatment. Coarsely milled 30 mg ER tablets demonstrated significantly lower maximum plasma concentration (Cmax ) and partial areas under the concentration-time curve (AUCs) than those of the finely milled IR tablets. Finely milled ER tablets demonstrated similar Cmax and partial AUCs but higher total systemic exposures than those of finely milled IR tablets. Finely milled 80 mg ER tablets were bioequivalent to IR tablet on all parameters. The finely milled 30 mg ER tablet was not bioequivalent to the coarsely milled 30 mg ER tablet and had higher values for all parameters. The finely milled 30 mg ER tablets (EDR 6.9) showed no PK differences with finely milled 80 mg ER tablets (EDR 4.9). No serious adverse events were reported. The study demonstrated a significant effect of particle sizes (106-1000 µm) on PK of milled and insufflated oxycodone ER AD tablets. EDR difference did not have any significant effects on the PK of finely milled oxycodone ER AD tablets. Particle size distribution should be considered when nasal AD properties of opioid drug products are investigated during drug development." @default.
• W3160490316 created "2021-05-24" @default.
• W3160490316 creator A5000559517 @default.
• W3160490316 creator A5004723627 @default.
• W3160490316 creator A5008178617 @default.
• W3160490316 creator A5009853512 @default.
• W3160490316 creator A5010611363 @default.
• W3160490316 creator A5011859108 @default.
• W3160490316 creator A5013453267 @default.
• W3160490316 creator A5020943905 @default.
• W3160490316 creator A5031712209 @default.
• W3160490316 creator A5031909358 @default.
• W3160490316 creator A5037989073 @default.
• W3160490316 creator A5056368358 @default.
• W3160490316 date "2021-06-02" @default.
• W3160490316 modified "2023-09-30" @default.
• W3160490316 title "Particle size affects pharmacokinetics of milled oxycodone hydrochloride tablet products following nasal insufflation in nondependent, recreational opioid users" @default.
• W3160490316 cites W1837086671 @default.
• W3160490316 cites W1971473849 @default.
• W3160490316 cites W1977625407 @default.
• W3160490316 cites W2037869134 @default.
• W3160490316 cites W2045670750 @default.
• W3160490316 cites W2066362724 @default.
• W3160490316 cites W2082095891 @default.
• W3160490316 cites W2106536537 @default.
• W3160490316 cites W2115221134 @default.
• W3160490316 cites W2128082475 @default.
• W3160490316 cites W2288234791 @default.
• W3160490316 cites W2330130766 @default.
• W3160490316 cites W2520364937 @default.
• W3160490316 cites W2739913519 @default.
• W3160490316 cites W2800089380 @default.
• W3160490316 cites W2906591149 @default.
• W3160490316 cites W4234381491 @default.
• W3160490316 cites W4247665917 @default.
• W3160490316 doi "https://doi.org/10.1111/cts.13053" @default.
• W3160490316 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8504826" @default.
• W3160490316 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33982418" @default.
• W3160490316 hasPublicationYear "2021" @default.
• W3160490316 type Work @default.
• W3160490316 sameAs 3160490316 @default.
• W3160490316 citedByCount "1" @default.
• W3160490316 countsByYear W31604903162023 @default.
• W3160490316 crossrefType "journal-article" @default.
• W3160490316 hasAuthorship W3160490316A5000559517 @default.
• W3160490316 hasAuthorship W3160490316A5004723627 @default.
• W3160490316 hasAuthorship W3160490316A5008178617 @default.
• W3160490316 hasAuthorship W3160490316A5009853512 @default.
• W3160490316 hasAuthorship W3160490316A5010611363 @default.
• W3160490316 hasAuthorship W3160490316A5011859108 @default.
• W3160490316 hasAuthorship W3160490316A5013453267 @default.
• W3160490316 hasAuthorship W3160490316A5020943905 @default.
• W3160490316 hasAuthorship W3160490316A5031712209 @default.
• W3160490316 hasAuthorship W3160490316A5031909358 @default.
• W3160490316 hasAuthorship W3160490316A5037989073 @default.
• W3160490316 hasAuthorship W3160490316A5056368358 @default.
• W3160490316 hasBestOaLocation W31604903161 @default.
• W3160490316 hasConcept C112705442 @default.
• W3160490316 hasConcept C126322002 @default.
• W3160490316 hasConcept C147789679 @default.
• W3160490316 hasConcept C170493617 @default.
• W3160490316 hasConcept C185592680 @default.
• W3160490316 hasConcept C187530423 @default.
• W3160490316 hasConcept C192562407 @default.
• W3160490316 hasConcept C22979827 @default.
• W3160490316 hasConcept C2776029756 @default.
• W3160490316 hasConcept C2781063702 @default.
• W3160490316 hasConcept C42404028 @default.
• W3160490316 hasConcept C43617362 @default.
• W3160490316 hasConcept C71924100 @default.
• W3160490316 hasConcept C98274493 @default.
• W3160490316 hasConceptScore W3160490316C112705442 @default.
• W3160490316 hasConceptScore W3160490316C126322002 @default.
• W3160490316 hasConceptScore W3160490316C147789679 @default.
• W3160490316 hasConceptScore W3160490316C170493617 @default.
• W3160490316 hasConceptScore W3160490316C185592680 @default.
• W3160490316 hasConceptScore W3160490316C187530423 @default.
• W3160490316 hasConceptScore W3160490316C192562407 @default.
• W3160490316 hasConceptScore W3160490316C22979827 @default.
• W3160490316 hasConceptScore W3160490316C2776029756 @default.
• W3160490316 hasConceptScore W3160490316C2781063702 @default.
• W3160490316 hasConceptScore W3160490316C42404028 @default.
• W3160490316 hasConceptScore W3160490316C43617362 @default.
• W3160490316 hasConceptScore W3160490316C71924100 @default.
• W3160490316 hasConceptScore W3160490316C98274493 @default.
• W3160490316 hasIssue "5" @default.
• W3160490316 hasLocation W31604903161 @default.
• W3160490316 hasLocation W31604903162 @default.
• W3160490316 hasLocation W31604903163 @default.
• W3160490316 hasLocation W31604903164 @default.
• W3160490316 hasOpenAccess W3160490316 @default.
• W3160490316 hasPrimaryLocation W31604903161 @default.
• W3160490316 hasRelatedWork W1989480569 @default.
• W3160490316 hasRelatedWork W2033685750 @default.
• W3160490316 hasRelatedWork W2053536280 @default.
• W3160490316 hasRelatedWork W2055974197 @default.
• W3160490316 hasRelatedWork W2381431760 @default.
• W3160490316 hasRelatedWork W2385472588 @default.

• next